BridgeMD
New treatment option for Cardiomyopathy, Myocarditis, Ischemic Heart Disease
Official title Quantitative Cardiac Parametric Mapping
ClinicalTrials.gov ID: NCT02855554
What this study is testing
- What it's testing
- The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases, such as ischemic heart disease, cardiomyopathies, and myocarditis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90. Healthy volunteers may be eligible.
You may be able to join if
- Subject must be 18-90 years of age.
- Subject must be previously diagnosed with or suspected to have one of the following conditions.
- Myocardial ischemia or infarction (group 1)
- Hypertrophic cardiomyopathy (group 2)
- Infiltrative cardiomyopathy (group 3)
You likely can't join if
- Subject has any implanted device or condition in which an MR scan would be contraindicated.
- Subject has an acute psychiatric disorder or is cognitively impaired.
- Subject is using or is dependent on substances of abuse.
- Subject is unwilling to comply with the requirements of the protocol.
- Subject has previously entered this study.
- Subject has an allergy against MRI contrast agents.
See the full eligibility criteria
- Subject must be 18-90 years of age.
- Subject must be previously diagnosed with or suspected to have one of the following conditions.
- Myocardial ischemia or infarction (group 1)
- Hypertrophic cardiomyopathy (group 2)
- Infiltrative cardiomyopathy (group 3)
- Myocarditis (group 4)
- Subject must have been referred for a clinically indicated CMR.
- Subject has any implanted device or condition in which an MR scan would be contraindicated.
- Subject has an acute psychiatric disorder or is cognitively impaired.
- Subject is using or is dependent on substances of abuse.
- Subject is unwilling to comply with the requirements of the protocol.
- Subject has previously entered this study.
- Subject has an allergy against MRI contrast agents.
- Subject is in acute unstable condition.
The study team makes the final eligibility decision.
Where it's taking place
- Charleston, South Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Charleston, South Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.